Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage

No longer listed by FDA — Sun Pharmaceutical Industries, Inc.

The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Sun Pharmaceutical Industries, Inc. with status No longer listed by FDA. The shortage was first posted on Jul 14, 2023. Reported reason: Other

Shortage details

Status
No longer listed by FDA
Company
Sun Pharmaceutical Industries, Inc.
Package NDC
57664-047-88
Dosage Form
Capsule
Presentation
Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 57664-047-88)
Initial Posting
Jul 14, 2023

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.